Tirzepatide (GLP-2)

Tirzepatide (GLP-2)

Characteristics

• Chemical Name: Tirzepatide (Research Grade)
• Other Name(s): Dual GLP-1/GIP receptor agonist peptide; LY3298176 (research designation), GLP-2
• CAS: 2023788-19-2
• Powder Purity: ≥ 98% (HPLC)
• Solubility: Soluble in water, PBS, and dilute acidic buffers (e.g., acetic acid); solubility dependent on pH and concentration
• Molar Mass: ~ 4,814.6 g/mol
• Chemical Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Shelf Life: Up to 24 months when stored lyophilized at −20 °C or below, protected from moisture and light
• Appearance: White to off-white lyophilized powder
• Biological Half-Life: Approximately 5 days (prolonged via C20 fatty diacid modification; research reference value)
• Safety Compliance:
  • Not approved for human or animal consumption
  • Not intended for diagnostic, therapeutic, or clinical use
  • Handle by trained professionals using appropriate laboratory safety procedures

Description

Tirzepatide is a synthetic peptide research chemical (CAS 2023788-19-2) that functions as a dual agonist of the GLP-1 and GIP receptors, two key regulators of glucose metabolism and energy balance. It is supplied as a lyophilized powder intended strictly for in-vitro laboratory research and scientific study. Tirzepatide’s unique peptide structure (≈39 amino acids with a C20 fatty diacid modification) gives it prolonged stability and receptor activity compared to single-pathway incretin analogs. This compound is not for human or animal consumption and should be handled only by qualified professionals for educational, analytical or experimental purposes.

WARNING: THIS COMPOUND IS FOR LABORATORY USE ONLY. ALL PRODUCTS ARE STRICTLY FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN CONSUMPTION.